Interventions to enhance patient adherence to medication prescriptions: Scientific review

JAMA

Volumn 288, Issue 22, 2002, Pages 2868-2879

  McDonald, Heather P ^a   Garg, Amit X ^a   Haynes, R Brian ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; COCHRANE LIBRARY; COUNSELING; DRUG MONITORING; EMBASE; FAMILY THERAPY; FOLLOW UP; HUMAN; LONG TERM CARE; MEDLINE; MENTAL DISEASE; META ANALYSIS; PATIENT CARE; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; PSYCINFO; REINFORCEMENT; SELF MONITORING; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

EID: 0037065355     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.288.22.2868     Document Type: Article

References (58)

1. Haynes RB. Improving patient adherence: State of the art, with a special focus on medication taking for cardiovascular disorders. In: Compliance in Health Care and Research. Burke LE, Ockene IS, eds. New York, NY: Futura Publishing Co Inc; 2001:3-21.
2. Haynes RB, McDonald H, Garg AX. Interventions for Helping Patients to Follow Prescriptions for Medications [Cochrane Review on CD-ROM]. Oxford, England: Cochrane Library, Update Software; 2002; issue 2.
3. Inzucchi SE. Oral hypoglycemic therapy for type 2 diabetes: Scientific review. JAMA. 2002;287:360-372.
4. Sackett DL, Snow JC. Compliance in Health Care. Baltimore, Md: Johns Hopkins University Press; 1979: 11-22.
5. Haynes RB. Determinants of compliance: The disease and the mechanisms of treatment. Haynes RB, Taylor DW, Sackett DL, eds. Compliance in Health Care. Baltimore, Md: Johns Hopkins University Press; 1979:49-62.
6. Houston MN, Hill M, Kottke T, et al. The multilevel compliance challenge: Recommendations for a call to action. Circulation. 1997;95:1085-1090.
7. Burke LE, Dunbar-Jacobs JM, Hill MN. Compliance with cardiovascular disease prevention strategies: A review of the research. Ann BehavMed. 1997; 19:239-263.
8. Gordis L. Conceptual and methodological problems in measuring compliance. In: Haynes RB, Taylor DW, Sackett DL, eds. Compliance in Health Care. Baltimore, Md: Johns Hopkins University Press; 1979: 23-25.
9. Haynes RB, Dantes R. Patient compliance in the design and interpretation of clinical trials. Control Clin Trial. 1987;8:12-19.
10. Irvine J, Baker B, Smith J, et al. Poor adherence to placebo or amiodarone therapy predicts mortality: Results from the CAMIAT study. Psychosom Med. 1999;61:566-575.
11. Jadad AR, Moore A, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trial. 1996;17:1-12.
12. Bandura A. Social Learning Theory. New York, NY: General Learning Press; 1971.
13. Harvey EL, Glenny A, Kirk SFL, Summerbell CD. Improving Health Professionals' Management and the Organization of Care for Overweight and Obese People [Cochrane Review on CD-ROM]. Oxford, England: Cochrane Library, Update Software; 1999; issue 2.
14. Volmink J, Garner P. Interventions for Promoting Adherence to Tuberculosis Treatment [Cochrane Review on CD-ROM]. Oxford, England: Cochrane Library, Update Software; 1999; issue 2.
15. Lumley J, Oliver S, Waters E. Interventions for Promoting Smoking Cessation During Pregnancy [Cochrane Review on CD-ROM]. Oxford, England: Cochrane Library, Update Software; 1999; issue 2.
16. Lancaster T, Stead LF. Self-Help Interventions for Smoking Cessation [Cochrane Review on CD-ROM]. Oxford, England: Cochrane Library, Update Software; 1999; issue 2.
17. Silagy C, Mant D, Fowler G, Lancaster T. Nicotine Replacement Therapy for Smoking Cessation [Cochrane Review on CD-ROM]. Oxford, England: Cochrane Library, Update Software; 1999; issue 2.
18. Gibson PG, Coughlan J, Wilson AJ, et al. Limited (Information Only) Patient Education Programs for Adults With Asthma [Cochrane Review on CD-ROM]. Oxford, England: Cochrane Library, Update Software; 1999; issue 2.
19. Bailey WC, Richards JM Jr, Brooks CM, et al. A randomized trial to improve self-management practices of adults with asthma. Arch Intern Med. 1990; 150:1664-1668.
20. Baird MG, Bentley-Taylor MM, Carruthers SG, et al. A study of efficacy, tolerance and compliance of once-daily versus twice-daily metoprolol (Betaloc) in hypertension: Betaloc Compliance Canadian Cooperative Study Group. Clin Invest Med. 1984;7:95-102.
21. Becker LA, Glanz K, Sobel E, et al. A randomized trial of special packaging of antihypertensive medications. J Fam Pract. 1986;22:357-361.
22. Brown BG, Bardsley J, Poulin D, et al. Moderate dose, three-drug therapy with niacin, lovastatin, and colestipol to reduce low-density lipoprotein cholesterol <100mg/dL in patients with hyperlipidemia and coronary artery disease. Am J Cardiol. 1997;80:111-115.
23. Brus HL, van de Laar MA, Taal E, Rasker JJ, Wiegman O. Effects of patient education on compliance with basic treatment regimens and health in recent onset active rheumatoid arthritis. Ann Rheum Dis. 1998; 57:146-151.
24. Chaplin R, Kent A. Informing patient about tardive dyskinesia: Controlled trial of patient education. Br J Psychiatry. 1998;172:78-81.
25. Colcher IS, Bass JW. Penicillin treatment of streptococcal pharyngitis: A comparison of schedules and the role of specific counseling. JAMA. 1972;222:657-659.
26. Cote J, Cartier A, Robichaud P, et al. Influence of asthma morbidity of asthma education programs based on self-management plans following treatment optimization. Am J Respir Crit Care Med. 1997; 155:1509-1514.
27. Friedman RH, Kazis LE, Jette A, et al. A telecommunications system for monitoring and counseling patients with hypertension: Impact on medication adherence and blood pressure control. Am J Hypertens. 1996;9:285-292.
28. Girvin B, McDermott BJ, Johnston D. A comparison of enalapril 20mg once daily vs 10mg twice daily in terms of blood pressure lowering and patient compliance. J Hypertens. 1999;17:1627-1631.
29. Gallefoss F, Bakke PS. How does patient education and self-management among asthmatics and patients with chronic obstructive pulmonary disease affect medication? Am J Respir Crit Care Med. 1999;160:2000-2005.
30. Haynes RB, Sackett DL, Gibson ES, et al. Improvement of medication compliance in uncontrolled hypertension. Lancet. 1976;1:1265-1268.
31. Henry A, Batey RG. Enhancing compliance not a prerequisite for effective eradication of Helicobacter pylori: The HelP Study. Am J Gastroenterol. 1999;94:811-815.
32. Howland JS, Baker MG, Poe T. Does patient education cause side effects? A controlled trial. J Fam Pract. 1990;31:62-64.
33. Johnson AL, Taylor DW, Sackett DL, et al. Self recording of blood pressure in the management of hypertension. CMAJ. 1978;119:1034-1039.
34. Knobel H, Carmona A, Lopez LJ, et al. Adherence to very active antiretroviral treatment: Impact of individualized assessment [in Spanish]. Enferm Infecc Microbiol Clin. 1999;17:78-81.
35. Katon W, Rutter C, Ludman EJ, et al. A randomized trial of relapse prevention of depression in primary care. Arch Gen Psychiatry. 2001;58:241-247.
36. Kemp R, Hayward P, Applewhaite G, et al. Compliance therapy in psychotic patients: Randomised controlled trial. BMJ. 1996;312:345-349.
37. Kemp R, Kirov G, Everitt B, et al. Randomised controlled trial of compliance therapy: 18-Month follow-up. Br J Psychiatry. 1998;172:413-419.
38. Levy ML, Robb M, Allen J, et al. A randomized controlled evaluation of specialist nurse education following accident and emergency department attendance for acute asthma. Respir Med. 2000;94:900-908.
39. Logan AG, Milne BJ, Achber C, et al. Work-site treatment of hypertension by specially trained nurses. Lancet. 1979;2:1175-1178.
40. Merinder LB, Viuff AG, Laugesen HD, et al. Patient and relative education in community psychiatry: A randomized controlled trial regarding its effectiveness. Soc Psychiatry Psychiatr Epidemiol. 1999; 34:287-294.
41. Peterson GM, McLean S, Millingen KS. A randomised trial of strategies to improve patient compliance with anticonvulsant therapy. Epilepsia. 1984;25:412-417.
42. Peveler R, George C, Kinmonth AL, et al. Effect of antidepressant drug counseling and information leaflets on adherence to drug treatment in primary care: Randomized controlled trial. BMJ. 1999;319:612-615.
43. Piette JD, Weinberger M, McPhee SJ, et al. Do automated calls with nurse follow-up improve selfcare and glycemic control among vulnerable patients with diabetes? Am J Med. 2000;108:20-27.
44. Razali SM, Hasanah CI, Khan UA, Subramaniam M. Psychosocial interventions for schizophrenia. J Mental Health. 2000;9:283-289.
45. Sackett DL, Haynes RB, Gibson ES, et al. Randomised clinical trial of strategies for improving medication compliance in primary hypertension. Lancet. 1975;1:1205-1207.
46. Strang JS, Falloon IRH, Moss HB, et al. The effects of family therapy on treatment compliance in schizophrenia. Psychopharmacol Bull. 1981;17:87-88.
47. Tuldra A, Fumaz CR, Ferrer MJ, et al. Prospective randomized two-arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2000;25:221-228.
48. van Es SM, Colland VT, Nagelkerke AF, et al. An intervention programme using the ASE-model aimed at enhancing adherence in adolescents with asthma. Patient Educ Couns. 2001;44:193-203.
49. Wysocki T, Greco P, Harris MA, et al. Behavior therapy for families of adolescents with diabetes: Maintenance of treatment effects. Diabetes Care. 2001;24:441-446.
50. Xiong W, Phillips MR, Hu X, et al. Family-based intervention for schizophrenic patient in China: A randomised controlled trial. Br J Psychiatry. 1994;165:239-247.
51. Zhang M, Wang M, Li J, Phillips MR. Randomised control of family intervention for 78 first-episode male schizophrenic patients: An 18-month study in Suzhou, Jiangsu. Br J Psychiatry. 1994;165(suppl 24):96-102.
52. Gallefoss F, Bakke PS, Kjaersgaard P. Quality of life assessment after patient education in a randomized controlled study on asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;159:812-817.
53. Logan AS, Milne BJ, Achber C, et al. Costeffectiveness of a worksite hypertension treatment program. Hypertension. 1981;3:211-218.
54. Macharia WM, Leon G, Rowe BH, et al. An overview of interventions to improve compliance with appointment keeping for medical services. JAMA. 1992; 267:1813-1817
55. Dickerson K, Min Y-I, Meinert CL. Factors influencing publication of research results: Follow-up applications submitted to 2 institutional review boards. JAMA. 1992;267:374-378.
56. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR. Publication bias in clinical research. Lancet. 1991; 337:867-872.
57. Stephenson BJ, Rowe BH, Haynes RB, et al. Is the patient taking the treatment as prescribed? JAMA. 1993;269:2779-2781.
58. Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo: The Cardiac Arrhythmia Suppression Trial. N Engl J Med. 1991;324:781-788.